Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autonomic and Renal Contributions to Hypertension With Androgen Deprivation Therapy

NCT05700903 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT05700903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05700903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autonomic and Renal Contributions to Hypertension With Androgen Deprivation Therapy
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Terminated
Start date
September 20, 2023
Completion date
July 16, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgen deprivation therapy, autonomic dysfunction, hypertension, prostate cancer, renal disease